Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
CollPlant Biotechnologies (NASDAQ:CLGN) reported its Q3 earnings results on Wednesday, November 29, 2023 at 07:00 AM.
Here's what investors need to know about the announcement.
CollPlant Biotechnologies missed estimated earnings by 169.23%, reporting an EPS of $-0.35 versus an estimate of $-0.13.
Revenue was down $66 thousand from the same period last year.
Last quarter the company beat on EPS by $0.51 which was followed by a 5.23% increase in the share price the next day.
To track all earnings releases for CollPlant Biotechnologies visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: CLGN